Literature DB >> 9083346

A prospective study of endogenous serum hormone concentrations and breast cancer risk in premenopausal women on the island of Guernsey.

H V Thomas1, T J Key, D S Allen, J W Moore, M Dowsett, I S Fentiman, D Y Wang.   

Abstract

The associations between serum concentrations of oestradiol, progesterone, testosterone and sex hormone-binding globulin (SHBG) and risk of breast cancer in premenopausal women were investigated in a prospective study of breast cancer on the island of Guernsey. Sixty-two women diagnosed with breast cancer an average of 8 years subsequent to blood collection were matched for day of menstrual cycle, age and year of blood collection with 182 control subjects. Cases had a 12% higher mean oestradiol concentration over the whole menstrual cycle (P = 0.17) with a large difference at mid-cycle (75% higher, P = 0.04). Differences between cases and control subjects in progesterone (luteal phase), testosterone and SHBG were small and not statistically significant: luteal phase progesterone 9% lower in cases, P = 0.64; testosterone 4% higher, P = 0.57; SHBG 8% higher, P = 0.24. The small difference in oestradiol concentration could be aetiologically important, but larger prospective studies are needed.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9083346      PMCID: PMC2222732          DOI: 10.1038/bjc.1997.183

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  17 in total

1.  Androgens and breast cancer in premenopausal women.

Authors:  G Secreto; P Toniolo; P Pisani; C Recchione; A Cavalleri; G Fariselli; A Totis; S Di Pietro; F Berrino
Journal:  Cancer Res       Date:  1989-01-15       Impact factor: 12.701

2.  Relation of prediagnostic serum estrogen and androgen levels to breast cancer risk.

Authors:  J F Dorgan; C Longcope; H E Stephenson; R T Falk; R Miller; C Franz; L Kahle; W S Campbell; J A Tangrea; A Schatzkin
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  1996-07       Impact factor: 4.254

3.  Serum hormone levels in pre-menopausal Chinese women in Shanghai and white women in Los Angeles: results from two breast cancer case-control studies.

Authors:  L Bernstein; J M Yuan; R K Ross; M C Pike; R Hanisch; R Lobo; F Stanczyk; Y T Gao; B E Henderson
Journal:  Cancer Causes Control       Date:  1990-07       Impact factor: 2.506

Review 4.  The role of oestrogens and progestagens in the epidemiology and prevention of breast cancer.

Authors:  T J Key; M C Pike
Journal:  Eur J Cancer Clin Oncol       Date:  1988-01

5.  Binding of oestradiol to blood proteins and aetiology of breast cancer.

Authors:  J W Moore; G M Clark; S A Hoare; R R Millis; J L Hayward; M K Quinlan; D Y Wang; R D Bulbrook
Journal:  Int J Cancer       Date:  1986-11-15       Impact factor: 7.396

6.  Sex hormone levels in serum in relation to the development of breast cancer.

Authors:  D K Wysowski; G W Comstock; K J Helsing; H L Lau
Journal:  Am J Epidemiol       Date:  1987-05       Impact factor: 4.897

7.  Twenty-four-hour preoperative endocrine profiles in women with benign and malignant breast disease.

Authors:  W B Malarkey; L L Schroeder; V C Stevens; A G James; R R Lanese
Journal:  Cancer Res       Date:  1977-12       Impact factor: 12.701

8.  The relationships of SHBG with current and previous use of oral contraceptives and oestrogen replacement therapy.

Authors:  T J Key; M C Pike; J W Moore; R D Bulbrook; G M Clark; D S Allen; D Y Wang
Journal:  Contraception       Date:  1989-02       Impact factor: 3.375

9.  A liquid-phase immunoradiometric assay (IRMA) for human sex hormone binding globulin (SHBG).

Authors:  G L Hammond; M S Langley; P A Robinson
Journal:  J Steroid Biochem       Date:  1985-10       Impact factor: 4.292

10.  Sex hormone binding globulin and risk factors for breast cancer in a population of normal women who had never used exogenous sex hormones.

Authors:  J W Moore; T J Key; R D Bulbrook; G M Clark; D S Allen; D Y Wang; M C Pike
Journal:  Br J Cancer       Date:  1987-11       Impact factor: 7.640

View more
  35 in total

1.  Urinary estrogens and estrogen metabolites and subsequent risk of breast cancer among premenopausal women.

Authors:  A Heather Eliassen; Donna Spiegelman; Xia Xu; Larry K Keefer; Timothy D Veenstra; Robert L Barbieri; Walter C Willett; Susan E Hankinson; Regina G Ziegler
Journal:  Cancer Res       Date:  2011-12-05       Impact factor: 12.701

2.  Circulating anti-Müllerian hormone and breast cancer risk: A study in ten prospective cohorts.

Authors:  Wenzhen Ge; Tess V Clendenen; Yelena Afanasyeva; Karen L Koenig; Claudia Agnoli; Louise A Brinton; Joanne F Dorgan; A Heather Eliassen; Roni T Falk; Göran Hallmans; Susan E Hankinson; Judith Hoffman-Bolton; Timothy J Key; Vittorio Krogh; Hazel B Nichols; Dale P Sandler; Minouk J Schoemaker; Patrick M Sluss; Malin Sund; Anthony J Swerdlow; Kala Visvanathan; Mengling Liu; Anne Zeleniuch-Jacquotte
Journal:  Int J Cancer       Date:  2018-02-08       Impact factor: 7.396

Review 3.  Estrogens in the breast tissue: a systematic review.

Authors:  Lusine Yaghjyan; Graham A Colditz
Journal:  Cancer Causes Control       Date:  2011-02-01       Impact factor: 2.506

4.  Endogenous estrogen, testosterone and progesterone levels in relation to breast cancer risk.

Authors:  Susan E Hankinson; A Heather Eliassen
Journal:  J Steroid Biochem Mol Biol       Date:  2007-05-24       Impact factor: 4.292

Review 5.  Circulating sex steroids and breast cancer risk in premenopausal women.

Authors:  Susan E Hankinson; A Heather Eliassen
Journal:  Horm Cancer       Date:  2010-02-09       Impact factor: 3.869

Review 6.  Estrogen metabolism and breast cancer.

Authors:  Hamed Samavat; Mindy S Kurzer
Journal:  Cancer Lett       Date:  2014-04-28       Impact factor: 8.679

7.  Circulating estrogen metabolites and risk for breast cancer in premenopausal women.

Authors:  Alan A Arslan; Roy E Shore; Yelena Afanasyeva; Karen L Koenig; Paolo Toniolo; Anne Zeleniuch-Jacquotte
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-08       Impact factor: 4.254

8.  Body size in relation to urinary estrogens and estrogen metabolites (EM) among premenopausal women during the luteal phase.

Authors:  Jing Xie; A Heather Eliassen; Xia Xu; Charles E Matthews; Susan E Hankinson; Regina G Ziegler; Shelley S Tworoger
Journal:  Horm Cancer       Date:  2012-08-04       Impact factor: 3.869

9.  Body fatness throughout the life course and the incidence of premenopausal breast cancer.

Authors:  Fei Xue; Bernard Rosner; Heather Eliassen; Karin B Michels
Journal:  Int J Epidemiol       Date:  2016-07-27       Impact factor: 7.196

10.  Reproducibility of fifteen urinary estrogens and estrogen metabolites over a 2- to 3-year period in premenopausal women.

Authors:  A Heather Eliassen; Regina G Ziegler; Bernard Rosner; Timothy D Veenstra; John M Roman; Xia Xu; Susan E Hankinson
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-10-20       Impact factor: 4.254

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.